Prediction of Left Ventricular Systolic Dysfunction Using an Artificial Intelligence-Based Electrocardiogram Analysis Model in Patients Presenting to the Emergency Department
Aug 2026· Diagnostics· Vol 16, pp. 2587· 0 citations· 26 references
Medicine
TL;DR
The AI-ECG model accurately identified LVSD in ED patients in this cohort despite heterogeneous acquisition conditions and retained good discrimination in hemodynamically unstable subgroups, although findings in the smaller hypotensive subgroup should be interpreted as exploratory.
Abstract
Background: Left ventricular systolic dysfunction (LVSD) is a precursor to heart failure arising from diverse cardiac conditions. Although echocardiography remains the reference standard for LVSD diagnosis, its routine use in the emergency department (ED) may be constrained by cost, time, equipment availability, and the need for specialized expertise. We evaluated the diagnostic performance of an artificial intelligence-based electrocardiogram analysis model (AI-ECG model) for detecting LVSD in patients presenting to the ED. Methods: This retrospective observational study included patients treated at a single tertiary hospital between 2020 and 2022 who underwent 12-lead electrocardiography within 24 h of ED admission and echocardiography within 30 days. Electrocardiographic data were analyzed using AiTiALVSD version 1.00.00, with a predefined cutoff score of 9.7 used to classify patients as being at high or low risk of LVSD. Diagnostic performance was assessed using standard discrimination and classification metrics. Results: Among 4529 included patients, 531 had LVSD. The AI-ECG model demonstrated high discrimination, with an area under the receiver operating characteristic curve (AUROC) of 0.934 (95% confidence interval [CI]: 0.923–0.945). Performance remained robust in patients with a shock index ≥ 0.9 (n = 453; AUROC, 0.895; 95% CI: 0.854–0.937) and in those with hypotension (n = 75; AUROC, 0.885; 95% CI: 0.786–0.984). Conclusions: The AI-ECG model accurately identified LVSD in ED patients in this cohort despite heterogeneous acquisition conditions and retained good discrimination in hemodynamically unstable subgroups, although findings in the smaller hypotensive subgroup should be interpreted as exploratory.
Artificial intelligence-enhanced electrocardiography demonstrated good diagnostic performance for detecting LVDD and may support future rule-out or risk-enrichment strategies in selected populations, however, current evidence remains insufficient to support routine clinical implementation.
Johann A. C. Edjimbi, Nisarg Shah, L. Donisi et al.· European Heart Journal - Dig...· 1 citation
Background/Objectives: Artificial intelligence-enabled electrocardiography (AI-ECG) can infer left ventricular systolic dysfunction (LVSD) and diastolic dysfunction (LVDD) from a standard 12-lead tracing. Whether these structural AI-ECG scores predict incident atrial fibrillation (AF) in patients in sinus rhythm, and how their predictive value changes over time, is unclear. Methods: In a retrospective single-center cohort of patients with a sinus-rhythm index ECG, AI-ECG LVSD and LVDD scores were derived and dichotomized at prespecified cutoffs (LVSD ≥ 9.7; LVDD ≥ 20.8). The outcome was incident AF, assessed within 30, 90, 180, 270, and 365 days. Discrimination was quantified by the AUROC. Because the proportional hazards assumption was violated, the time course of risk for the joint LVSD × LVDD classification was characterized with window-specific Cox, Aalen additive hazards, and restricted mean survival time analyses. Results: Among 19,593 index ECGs from 18,984 patients, 1190 (6.07%) were followed by incident AF within one year. One-year incidence rose from 4.1% (both negative) to 9.8% (LVSD-positive only), 20.1% (LVDD-positive only), and 19.9% (both positive). Discrimination was highest for early events and attenuated over time, more steeply for LVSD (AUROC 0.803 at 30 days to 0.713 at 365 days) than LVDD (0.817 to 0.764). Combining AI-ECG LVSD and LVDD models, the excess risk conferred by dual positivity was concentrated in the first weeks after the index ECG and, consistently across cumulative Cox, Aalen additive hazards, and restricted mean survival time analyses, converged with that of isolated LVDD positivity by one year. Conclusions: Structural AI-ECG LVSD and LVDD scores from a single sinus-rhythm ECG predict incident AF in a time-dependent manner, with the strongest performance shortly after acquisition and more durable discrimination for LVDD. A single AI-ECG may help target short-term AF surveillance, particularly in patients with combined systolic–diastolic dysfunction.
Kyung Su Kim, J. Son, H. Lee et al.· Diagnostics· 0 citations
Adding AI-ECG signals to PREVENT-HF improves near-term heart-failure risk discrimination and reclassification, though without demonstrated benefit on clinical outcomes such as heart-failure hospitalization or mortality.
A. Bollmann, V. Pradler, D. Husser et al.· Frontiers in Cardiovascular...· 0 citations
In this single-center exploratory cohort of patients with obstructive hypertrophic cardiomyopathy receiving mavacamten, ECG-Vision left ventricular demonstrated high observed sensitivity and negative predictive value for TTE-defined LVSD, although estimates were imprecise because LVSD events were infrequent.
Aakash Bavishi, John Fritzlen, Marybeth Soutar et al.· Circulation: Heart Failure· 0 citations
Routinely available ECG-derived P-wave dispersion and echocardiographic LAVI are independent, complementary predictors of MACE in CAD patients, and integrating these two parameters into a simple risk model significantly enhances risk discrimination and reclassification, providing a practical, cost-effective tool for individualized management.
Qin Wu, Gang Chen, Jian Chang· Frontiers in Medicine· 0 citations
A composite artificial intelligence-enabled electrocardiogram (AI-ECG) identified prevalent and predicted incident Structural heart disease (SHD) across multinational cohorts, capturing signals beyond its training targets and supporting its potential as a scalable cardiovascular screening tool.
H. Lee, S. Kang, M. Lee et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.